Trevena Appoints Robert Prachar as Senior Vice President, Commercial and Corporate Strategy Apr 1, 2014 7:00 am EDT
Trevena to Host Conference Call on March 20th to Discuss Full Year 2013 Financial Results and Recent Highlights Mar 13, 2014 4:16 pm EDT
Trevena Initiates Clinical Development of TRV734, a Novel Biased Ligand for Moderate to Severe Pain Feb 5, 2014 7:00 am EST
Trevena Announces Pricing of Initial Public Offering of 9,250,000 Shares of Common Stock Jan 31, 2014 6:30 am EST